Sponsor Pipeline

Byondis B.V. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05737628 First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal… Lymphoma Active, Not Recruiting
NCT06932952 A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients… Solid Tumor Active, Not Recruiting
NCT06359002 Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia… Relapsed / Refractory AML Active, Not Recruiting
Disease Areas
Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Byondis B.V.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free